Literature DB >> 10711406

Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine.

F Musshoff1.   

Abstract

The interpretation of methamphetamine and amphetamine positive test results in biological samples is a challenge to clinical and forensic toxicology for several reasons. The effects of pH and dilution of urine samples and the knowledge about legitimate and illicit sources have to be taken into account. Besides a potentially legal prescription of amphetamines, many substances metabolize to methamphetamine or amphetamine in the body: amphetaminil, benzphetamine, clobenzorex, deprenyl, dimethylamphetamine, ethylamphetamine, famprofazone, fencamine, fenethylline, fenproporex, furfenorex, mefenorex, mesocarb, and prenylamine. Especially the knowledge of potential origins of methamphetamine and amphetamine turns out to be very important to prevent a misinterpretation of the surrounding circumstances and to prove illegal drug abuse. In this review, potential precursor compounds are described, including their medical use and major clinical effects and their metabolic profiles, as well as some clues which help to identify the sources.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711406     DOI: 10.1081/dmr-100100562

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  11 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent.

Authors:  Matthew N Newmeyer; Marta Concheiro; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2014-07-05       Impact factor: 4.759

3.  Death by 'ice': fatal methamphetamine intoxication of a body packer case detected by postmortem computed tomography (PMCT) and validated by autopsy.

Authors:  Saiful Nizam Bin Abdul Rashid; Amir Saad Abdul Rahim; Michael J Thali; Patricia M Flach
Journal:  Forensic Sci Med Pathol       Date:  2013-02-13       Impact factor: 2.007

Review 4.  Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors:  J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2010-11-04       Impact factor: 2.007

5.  Stereoselectivity in the human metabolism of methamphetamine.

Authors:  Linghui Li; Tom Everhart; Peyton Jacob Iii; Reese Jones; John Mendelson
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  A comparative analysis of protein targets of withdrawn cardiovascular drugs in human and mouse.

Authors:  Yuqi Zhao; Jingwen Wang; Yanjie Wang; Jingfei Huang
Journal:  J Clin Bioinforma       Date:  2012-05-01

8.  Detection of β-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS.

Authors:  Piotr Chołbiński; Mariola Wicka; Katarzyna Kowalczyk; Anna Jarek; Paweł Kaliszewski; Andrzej Pokrywka; Ewa Bulska; Dorota Kwiatkowska
Journal:  Anal Bioanal Chem       Date:  2014-03-16       Impact factor: 4.142

9.  A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.

Authors:  James Ermer; Mary Corcoran; Kenneth Lasseter; Thomas Marbury; Brian Yan; Patrick T Martin
Journal:  Ther Drug Monit       Date:  2016-08       Impact factor: 3.681

10.  Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose.

Authors:  Selina Hemmer; Lea Wagmann; Markus R Meyer
Journal:  Arch Toxicol       Date:  2021-08-19       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.